NZ204721A - N,n'-2,6-(pyrazinediyl)bis(2-oxoglycine) and derivatives: antiallergic compounds - Google Patents

N,n'-2,6-(pyrazinediyl)bis(2-oxoglycine) and derivatives: antiallergic compounds

Info

Publication number
NZ204721A
NZ204721A NZ204721A NZ20472183A NZ204721A NZ 204721 A NZ204721 A NZ 204721A NZ 204721 A NZ204721 A NZ 204721A NZ 20472183 A NZ20472183 A NZ 20472183A NZ 204721 A NZ204721 A NZ 204721A
Authority
NZ
New Zealand
Prior art keywords
give
alkyl
bis
formula
pyrazinediyl
Prior art date
Application number
NZ204721A
Other languages
English (en)
Inventor
S G Wood
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of NZ204721A publication Critical patent/NZ204721A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/16Halogen atoms; Nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NZ204721A 1982-06-30 1983-06-27 N,n'-2,6-(pyrazinediyl)bis(2-oxoglycine) and derivatives: antiallergic compounds NZ204721A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39395882A 1982-06-30 1982-06-30

Publications (1)

Publication Number Publication Date
NZ204721A true NZ204721A (en) 1987-05-29

Family

ID=23556946

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ204721A NZ204721A (en) 1982-06-30 1983-06-27 N,n'-2,6-(pyrazinediyl)bis(2-oxoglycine) and derivatives: antiallergic compounds

Country Status (16)

Country Link
EP (1) EP0097942B1 (nl)
JP (1) JPS597176A (nl)
KR (1) KR900001201B1 (nl)
AT (1) ATE28454T1 (nl)
AU (1) AU554357B2 (nl)
CA (1) CA1249588A (nl)
DE (1) DE3372614D1 (nl)
DK (1) DK160822C (nl)
ES (2) ES8600749A1 (nl)
GR (1) GR78588B (nl)
IE (1) IE55520B1 (nl)
IL (1) IL69103A0 (nl)
NO (1) NO832363L (nl)
NZ (1) NZ204721A (nl)
PH (1) PH19319A (nl)
ZA (1) ZA834644B (nl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788198A (en) * 1983-09-01 1988-11-29 Boehringer Ingelheim Pharmaceuticals, Inc. Diazine-ethyenylphenyl oxamic acids and esters and salts thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191840A (en) * 1973-03-23 1980-03-04 American Home Products Corporation Oxamic acid derivatives
US3963660A (en) * 1973-10-04 1976-06-15 The Upjohn Company Pyridine dioxamic acids and esters
US4017538A (en) * 1975-10-01 1977-04-12 The Upjohn Company Alkyl thio sulfinyl and sulfonyl oxamic compounds, compositions and methods of use

Also Published As

Publication number Publication date
NO832363L (no) 1984-01-02
ES523659A0 (es) 1985-11-01
CA1249588A (en) 1989-01-31
EP0097942B1 (en) 1987-07-22
IL69103A0 (en) 1983-10-31
IE831522L (en) 1983-12-30
JPS597176A (ja) 1984-01-14
IE55520B1 (en) 1990-10-10
JPH0551586B2 (nl) 1993-08-03
KR840005110A (ko) 1984-11-03
ES539117A0 (es) 1985-11-16
DE3372614D1 (en) 1987-08-27
ATE28454T1 (de) 1987-08-15
DK300183D0 (da) 1983-06-29
KR900001201B1 (ko) 1990-02-28
DK160822C (da) 1991-10-14
EP0097942A1 (en) 1984-01-11
DK300183A (da) 1983-12-31
AU1629083A (en) 1984-01-05
DK160822B (da) 1991-04-22
PH19319A (en) 1986-03-18
ZA834644B (en) 1984-03-28
ES8600749A1 (es) 1985-11-01
ES8601154A1 (es) 1985-11-16
AU554357B2 (en) 1986-08-21
GR78588B (nl) 1984-09-27

Similar Documents

Publication Publication Date Title
DE2822544C2 (nl)
DE2362409B2 (de) NJ4'<m-Phenylen)-dioxamidsäuren und deren Derivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
CH631696A5 (de) Verfahren zur herstellung von olefinischen derivaten von aminosaeuren.
JPS61293977A (ja) ピペラジン誘導体、その製造法及びそれを含む医薬
EP0498380A1 (de) Komplexbildner
DE2802493C2 (nl)
DE2525226C2 (de) Oxanilsäure oder Oxanilsäurederivate enthaltende pharmazeutische Mittel, Oxanilsäurederivate und Verfahren zu deren Herstellung
PT88004B (pt) Processo para a preparacao de guanidinas substituidas, contendo uma porcao tetrazole, uteis como agentes edulcorantes de elevada potencia
DE2360193A1 (de) Cyansubstituierte n,n'-(phenylen)-dioxamidsaeuren und deren salze, verfahren zu deren herstellung und dieselben enthaltende therapeutische mittel
NZ204721A (en) N,n'-2,6-(pyrazinediyl)bis(2-oxoglycine) and derivatives: antiallergic compounds
DK163238B (da) 3-(1h-tetrazol-5-yl)-2(1h)-quinolinon samt farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling af disse forbindelser
DE3887463T2 (de) Durch eine Alkoxy-oder Benzyloxy-Gruppe oder eine Benzylthio-Gruppe substituierte Di-t-butylphenole.
DE69719563T2 (de) Pharmazeutische wirksame trizyklische amine
DE2913295C2 (nl)
DE2630469C2 (de) 6-Alkoxy-N-(5-tetrazolyl)-1-oxo-1H-pyrimido-[1,2-a] chinolin-2-carboxamide, Verfahren zu deren Herstellung und dieselben enthaltende antiallergisch wirksame pharmazeutische Zubereitungen
DE3882785T2 (de) Di-t-butylphenylalkyl- und benzyläther.
CA1293251C (en) Pyrazine derivative, a process for preparation thereof and pharmaceutical composition therefrom
CA1041100A (en) Pyridine-diyldioxamic acid and derivatives
CA1219873A (en) Diazine-ethenyl-phenyl oxamic acids and esters and salts thereof
EP0377437B1 (de) Verfahren zur Herstellung von 2,4-Diamino-6-piperidinyl-pyrimidin-3-N-oxid
US4650872A (en) 5-chloro-s-triazolo[4,3-a]-pyridine-7-carboxylic acids, useful as antiallergic agents
DE3782619T2 (de) 1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente.
DE2649855C2 (de) Substituierte 5-Acetyl-4-hydroxy-3-phenylamino-2H-pyran-2,6(3H)-dione, Verfahren zu deren Herstellung und deren Verwendung
EP0132788B1 (en) 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide
AT365190B (de) Verfahren zur herstellung neuer 3-(1h-tetrazol5-yl)-4h-pyrimido(1,2-a)-pyrimidin-4-one und von deren salzen